Senvest Management, LLC - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 45 filers reported holding TRINITY BIOTECH PLC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Senvest Management, LLC ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q3 2018$4,016,000
-20.0%
1,003,9880.0%0.30%
-12.1%
Q2 2018$5,020,000
-2.9%
1,003,9880.0%0.35%
-12.2%
Q1 2018$5,171,000
+1.0%
1,003,9880.0%0.39%
+9.1%
Q4 2017$5,120,000
+2.3%
1,003,988
+12.5%
0.36%
+9.4%
Q3 2017$5,007,000
+16.9%
892,488
+25.0%
0.33%
-1.8%
Q2 2017$4,283,000
+48.6%
713,822
+47.6%
0.34%
+63.1%
Q1 2017$2,882,000
-9.8%
483,525
+4.8%
0.21%
-9.6%
Q4 2016$3,194,000
-60.8%
461,584
-25.2%
0.23%
-61.0%
Q3 2016$8,155,000
+16.6%
616,8460.0%0.58%
+2.1%
Q2 2016$6,995,000
-2.7%
616,8460.0%0.57%
-5.1%
Q1 2016$7,192,000
+2.5%
616,846
+3.4%
0.60%
+14.6%
Q4 2015$7,019,000
+6.4%
596,846
+3.5%
0.53%
+10.9%
Q3 2015$6,599,000
-33.4%
576,846
+5.2%
0.48%
-23.3%
Q2 2015$9,904,000
+476.5%
548,373
+514.4%
0.62%
+484.0%
Q1 2015$1,718,000
+48.1%
89,255
+34.8%
0.11%
+27.7%
Q4 2014$1,160,00066,2330.08%
Other shareholders
TRINITY BIOTECH PLC shareholders Q1 2018
NameSharesValueWeighting ↓
ACK Asset Management 672,100$14,625,0005.62%
GOLDMAN CAPITAL MANAGEMENT INC 312,000$6,789,0004.48%
Lyon Street Capital, LLC 407,586$8,870,047,0004.37%
GREAT POINT PARTNERS LLC 189,071$4,114,0002.85%
Adirondack Research & Management Inc. 161,507$3,514,0002.02%
Park West Asset Management LLC 483,355$10,518,0001.56%
Benchmark Capital Advisors 56,954$1,239,0000.89%
WOODMONT INVESTMENT COUNSEL LLC 76,607$1,667,0000.61%
SHEPHERD KAPLAN KROCHUK, LLC 156,000$3,394,0000.55%
HEARTLAND ADVISORS INC 1,250,364$27,208,0000.50%
View complete list of TRINITY BIOTECH PLC shareholders